GCGR and steatosis: Treatment with DualAG (protease‐resistant dual GLP1R/GCGR agonist) in a mouse model showed improvement in glucose tolerance in diet‐induced obese mice without causing hyperglycaemia, unlike typical GCGR activation; all while inducing weight loss, steatosis attenuation and lipid‐lowering effects (Pocai et al., 2009).